Treatment-related upper-limb morbidity one year after sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND) for stage I or II breast cancer
J. S. Rietman, P. U. Dijkstra, J. H. Geertzen, P. Baas, J. De Vries, W. Dolsma, J. W. Groothoff, W. H. Eisma, H. J. HoekstraVolume:
11
Language:
english
Pages:
1
DOI:
10.1007/bf02523974
Date:
February, 2004
File:
PDF, 292 KB
english, 2004